Recipharm
Kayserberg, France recipharm.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Recipharm is a global CDMO that develops and manufactures pharmaceutical products for small and large molecules, including oral solid doses, semi-solids, liquids, sterile products, controlled substances, vaccines, and advanced biologics. It serves pharmaceutical, biotech, veterinary, and other customers from a global network of facilities with local expertise.
Services
Oral solid dose development
Develops oral solid dose products from early phases to manufacturing readiness using a Quality-by-Design approach.
Oral solid dose manufacturing
Manufactures powders, granules, tablets, pellets, and hard capsules, including coated, uncoated, immediate-release, modified-release, and controlled-release forms.
Semi-solid formulation development and manufacturing
Develops and manufactures topical and transdermal semi-solid products such as creams, gels, ointments, pastes, and suppositories.
Liquid formulation and manufacturing
Develops and manufactures non-sterile and sterile liquid dosage forms including solutions, emulsions, suspensions, sprays, and aerosols.
Sterile vial filling
Provides aseptic vial filling and terminal sterilisation for liquid-filled or lyophilised vial products.
Pre-filled syringe and cartridge filling
Offers sterile filling of pre-filled syringes and pharmaceutical cartridges for parenteral products, including complex formulations.
Sterile lyophilisation
Provides aseptic freeze-drying and lyophilisation cycle development and optimisation for sterile pharmaceutical products.
Vaccine manufacturing
Supports vaccine manufacturing and aseptic fill-finish, including liquid and lyophilised mRNA COVID-19 vaccines.
21 more services
- Parenteral drug development
- Technology transfer
- New product introduction (NPI)
- Product development
- ReciPredict
- Controlled substance manufacturing
- Animal health drug product manufacturing
- Solid dosage form development and manufacturing
- Sterile fill & finish
- Lyophilisation
- Blow-fill-seal filling
- Ampoule manufacturing
- OSD drug development
- Analytical development
- Pharmaceutical analytical services
- Regulatory excellence
- New product introduction
- Microbial & live biotherapeutic products
- Recombinant proteins
- Virus & viral vectors
- xRNA therapies
Capabilities
- Assays and studies
- Lyophilization
- Fill-finish
- Analytical development
- mRNA
- Process development
- Small molecules
20 more
- Sterility testing
- Endotoxin testing
- Pharmacopoeia testing
- Method development
- Method validation
- Stability testing
- Dissolution studies
- Release analytics
- Elemental impurities
- Nitrosamine analytics
- Container closure integrity testing
- Viable particulate analysis
- Non-viable particulate analysis
- Extractables and leachables
- Impurity identification
- Stability studies
- Release testing
- Pharmacopeial testing
- Extractables and leachables (E&L)
- Elemental impurities testing
- Scale and capacity
- 16 facilities in 8 countries
- Commercial-scale manufacturing
- Clinical trial manufacturing
- High-volume vaccines
- Billions of doses of sterile products
- Up to OEB 5
4 more
- 17 facilities
- 8 countries
- 4,500+ people
- More than 250 ongoing stability studies concurrently
- Therapeutic areas
- Vaccines
- Animal health
- Biologics
- Injectables
- Ophthalmics
- Pulmonary
Instruments and platforms
- Relevant to not stated
- Mass spectrometry
- High-resolution mass spectrometry
- Preparative HPLC
- NMR
Modalities and species
- Modalities
- Small molecule
- mRNA
- Viral vector
- Recombinant protein
- Vaccine
- Plasmid DNA
- Species and models
- NCEs
- Generics
- Pharmaceuticals
- Biotech products
- Veterinary products
- Schedule I-V controlled substances
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
As listed: cGMP
ISO 14001Self-reported
Details
- Type
- CDMO
- Founded
- 1995
- Team
- 4,500+ people
- Based in
- Kayserberg, France
- Serves
- Global, Europe, USA
Public records
- Wikidata
- Q7302454 source